Quinn Opportunity Partners LLC Bristol Myers Squibb CO Transaction History

Quinn Opportunity Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $6.7 Million - $8.04 Million	-109,000 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $786,380 - $856,368	-12,702 Reduced 10.44%	109,000 $7.28 Million
Q1 2021 May 13, 2021	BUY	$59.34 - $66.74 $2.55 Million - $2.87 Million	43,053 Added 54.74%	121,702 $7.68 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $4.54 Million - $5.15 Million	78,649 New	78,649 $4.88 Million
Q2 2019 Aug 09, 2019	SELL	$44.62 - $49.34 $1.38 Million - $1.52 Million	-30,900 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$45.12 - $53.8 $1.39 Million - $1.66 Million	30,900 New	30,900 $1.47 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Quinn Opportunity Partners LLC with notifications on news.